

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.73123880 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 6.63489332 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.63489332 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 6.63489332 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.63489332 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.63489332 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.63489332 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.40209735 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.24847470 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.99020462 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.99020462 |
| 12 | * regulation of interferon-beta biosynthetic process (GO:0045357) | 4.96255769 |
| 13 | response to peptidoglycan (GO:0032494) | 4.80799384 |
| 14 | microglial cell activation (GO:0001774) | 4.66490783 |
| 15 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.66454396 |
| 16 | response to host immune response (GO:0052572) | 4.66454396 |
| 17 | * positive regulation of interferon-alpha production (GO:0032727) | 4.43247968 |
| 18 | * detection of external biotic stimulus (GO:0098581) | 4.42144887 |
| 19 | response to host (GO:0075136) | 4.25699380 |
| 20 | response to host defenses (GO:0052200) | 4.25699380 |
| 21 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.25699380 |
| 22 | detection of bacterium (GO:0016045) | 4.24758747 |
| 23 | * detection of other organism (GO:0098543) | 4.24758747 |
| 24 | * regulation of interferon-alpha production (GO:0032647) | 4.16373547 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 4.10563399 |
| 26 | respiratory burst (GO:0045730) | 4.05738548 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 4.03036197 |
| 28 | * detection of biotic stimulus (GO:0009595) | 3.97289420 |
| 29 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.91806583 |
| 30 | * positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.86486709 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.83766076 |
| 32 | myeloid cell activation involved in immune response (GO:0002275) | 3.76802882 |
| 33 | pinocytosis (GO:0006907) | 3.72617868 |
| 34 | neutrophil activation (GO:0042119) | 3.69902762 |
| 35 | positive regulation of antigen processing and presentation (GO:0002579) | 3.69556720 |
| 36 | cellular extravasation (GO:0045123) | 3.67960056 |
| 37 | * macrophage activation (GO:0042116) | 3.67265880 |
| 38 | granulocyte activation (GO:0036230) | 3.59716485 |
| 39 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.52216249 |
| 40 | myeloid leukocyte mediated immunity (GO:0002444) | 3.45507830 |
| 41 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.42284048 |
| 42 | negative regulation of mast cell activation (GO:0033004) | 3.40953954 |
| 43 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.38179348 |
| 44 | regulation of mast cell activation (GO:0033003) | 3.35202891 |
| 45 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.33255444 |
| 46 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.32777911 |
| 47 | leukocyte aggregation (GO:0070486) | 3.32095362 |
| 48 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.29226720 |
| 49 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.28231922 |
| 50 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.27405560 |
| 51 | superoxide anion generation (GO:0042554) | 3.23938998 |
| 52 | * positive regulation of interferon-beta production (GO:0032728) | 3.22748940 |
| 53 | positive regulation of mast cell activation (GO:0033005) | 3.21709436 |
| 54 | negative regulation of T cell mediated immunity (GO:0002710) | 3.21292824 |
| 55 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.21253427 |
| 56 | regulation of tolerance induction (GO:0002643) | 3.19222939 |
| 57 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.18254576 |
| 58 | germinal center formation (GO:0002467) | 3.17580556 |
| 59 | neutrophil mediated immunity (GO:0002446) | 3.17322797 |
| 60 | * detection of molecule of bacterial origin (GO:0032490) | 3.15427009 |
| 61 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.14677550 |
| 62 | regulation of antigen processing and presentation (GO:0002577) | 3.13827596 |
| 63 | positive regulation of B cell differentiation (GO:0045579) | 3.13362862 |
| 64 | regulation of mononuclear cell migration (GO:0071675) | 3.09499783 |
| 65 | regulation of mast cell degranulation (GO:0043304) | 3.09364509 |
| 66 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.09342278 |
| 67 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.09130984 |
| 68 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.08982262 |
| 69 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.08756179 |
| 70 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.07724716 |
| 71 | response to interferon-alpha (GO:0035455) | 3.04887179 |
| 72 | * regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.03963566 |
| 73 | phagocytosis, engulfment (GO:0006911) | 3.01919694 |
| 74 | regulation of T cell tolerance induction (GO:0002664) | 3.01579597 |
| 75 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.99249151 |
| 76 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.98794956 |
| 77 | * regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.98652208 |
| 78 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.97062872 |
| 79 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.96433487 |
| 80 | negative regulation of granulocyte differentiation (GO:0030853) | 2.94382978 |
| 81 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.92148723 |
| 82 | natural killer cell mediated immunity (GO:0002228) | 2.92148723 |
| 83 | apoptotic cell clearance (GO:0043277) | 2.91286694 |
| 84 | * myeloid leukocyte activation (GO:0002274) | 2.90671661 |
| 85 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.89265276 |
| 86 | positive regulation of mast cell degranulation (GO:0043306) | 2.89265276 |
| 87 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.88894799 |
| 88 | response to muramyl dipeptide (GO:0032495) | 2.88546696 |
| 89 | positive regulation of leukocyte degranulation (GO:0043302) | 2.88164058 |
| 90 | regulation of monocyte chemotaxis (GO:0090025) | 2.87564705 |
| 91 | negative regulation of lipid storage (GO:0010888) | 2.87079035 |
| 92 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.86847979 |
| 93 | B cell mediated immunity (GO:0019724) | 2.86629342 |
| 94 | neutrophil migration (GO:1990266) | 2.86261630 |
| 95 | dendritic cell migration (GO:0036336) | 2.86136113 |
| 96 | positive regulation of type 2 immune response (GO:0002830) | 2.85630144 |
| 97 | regulation of cholesterol storage (GO:0010885) | 2.85453426 |
| 98 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.85384504 |
| 99 | B cell receptor signaling pathway (GO:0050853) | 2.83169969 |
| 100 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.81557047 |
| 101 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.80690097 |
| 102 | * I-kappaB phosphorylation (GO:0007252) | 2.79362478 |
| 103 | * positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.78892183 |
| 104 | myeloid dendritic cell activation (GO:0001773) | 2.78479254 |
| 105 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.77996446 |
| 106 | response to interleukin-15 (GO:0070672) | 2.76189328 |
| 107 | positive regulation of chemokine secretion (GO:0090197) | 2.74816480 |
| 108 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.74808370 |
| 109 | leukocyte mediated cytotoxicity (GO:0001909) | 2.74381431 |
| 110 | positive regulation of tolerance induction (GO:0002645) | 2.73339529 |
| 111 | dendritic cell chemotaxis (GO:0002407) | 2.73332036 |
| 112 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.73330670 |
| 113 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.73330670 |
| 114 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.72487621 |
| 115 | * positive regulation of chemokine production (GO:0032722) | 2.72196976 |
| 116 | regulation of regulated secretory pathway (GO:1903305) | 2.71826277 |
| 117 | positive regulation of lymphocyte migration (GO:2000403) | 2.71516009 |
| 118 | response to type I interferon (GO:0034340) | 2.71280860 |
| 119 | cellular response to type I interferon (GO:0071357) | 2.69544874 |
| 120 | type I interferon signaling pathway (GO:0060337) | 2.69544874 |
| 121 | * positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.68827408 |
| 122 | regulation of B cell differentiation (GO:0045577) | 2.67434316 |
| 123 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.67110040 |
| 124 | reactive oxygen species biosynthetic process (GO:1903409) | 2.66508265 |
| 125 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.66430212 |
| 126 | cytokine secretion (GO:0050663) | 2.66063524 |
| 127 | regulation of type 2 immune response (GO:0002828) | 2.65685532 |
| 128 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.65651668 |
| 129 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.65209930 |
| 130 | negative regulation of type 2 immune response (GO:0002829) | 2.64644681 |
| 131 | regulation of leukocyte degranulation (GO:0043300) | 2.63713543 |
| 132 | myeloid dendritic cell differentiation (GO:0043011) | 2.63633491 |
| 133 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.63074914 |
| 134 | positive regulation of macrophage differentiation (GO:0045651) | 2.62998433 |
| 135 | neutrophil chemotaxis (GO:0030593) | 2.62703917 |
| 136 | * positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.60916655 |
| 137 | defense response to protozoan (GO:0042832) | 2.60532148 |
| 138 | positive regulation of T cell migration (GO:2000406) | 2.59700553 |
| 139 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.59565986 |
| 140 | * positive regulation of tumor necrosis factor production (GO:0032760) | 2.58571003 |
| 141 | negative regulation of interleukin-12 production (GO:0032695) | 2.58411755 |
| 142 | cellular response to interferon-alpha (GO:0035457) | 2.58318780 |
| 143 | dendritic cell differentiation (GO:0097028) | 2.58034943 |
| 144 | response to protozoan (GO:0001562) | 2.58016599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.30040064 |
| 2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.06077479 |
| 3 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.88253926 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.39192184 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.21625005 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.99910624 |
| 7 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.80351316 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.71791950 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.40520571 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.20345319 |
| 11 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.19287865 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.14202397 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.88746459 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.67459787 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.59981382 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.55708739 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.47136106 |
| 18 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.33661930 |
| 19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.31952690 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.28823681 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.10228548 |
| 22 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.00429491 |
| 23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.98778436 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.97154059 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.95160124 |
| 26 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.90969442 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.90862352 |
| 28 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.85015796 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.81192878 |
| 30 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.80320309 |
| 31 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78969696 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66948522 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.61193551 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56763171 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56619407 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.56102847 |
| 37 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.53412782 |
| 38 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.48780670 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47357024 |
| 40 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46836621 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.46294148 |
| 42 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.46280393 |
| 43 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.44252812 |
| 44 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.44069248 |
| 45 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41915256 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40347622 |
| 47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39314881 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.38306396 |
| 49 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.38064959 |
| 50 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.36349982 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31494961 |
| 52 | CJUN_26792858_Chip-Seq_BT549_Human | 1.30802597 |
| 53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30241734 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28755687 |
| 55 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27323150 |
| 56 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.26551045 |
| 57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25728786 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24047078 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24047078 |
| 60 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.23206105 |
| 61 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.23206105 |
| 62 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22788025 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22448908 |
| 64 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.21762149 |
| 65 | MAF_26560356_Chip-Seq_TH1_Human | 1.21208104 |
| 66 | MYB_26560356_Chip-Seq_TH1_Human | 1.20643821 |
| 67 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20341968 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19255611 |
| 69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18791385 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17246796 |
| 71 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15995391 |
| 72 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.15768000 |
| 73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15111869 |
| 74 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13146404 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13103326 |
| 76 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.12791305 |
| 77 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05763296 |
| 78 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05325973 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03858454 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03202174 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02997714 |
| 82 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.01510804 |
| 83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01462107 |
| 84 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.00798297 |
| 85 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00271327 |
| 86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99676939 |
| 87 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99636981 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 0.98453433 |
| 89 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98096949 |
| 90 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97006527 |
| 91 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96725140 |
| 92 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94764476 |
| 93 | MYC_22102868_ChIP-Seq_BL_Human | 0.93413501 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93319419 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93013539 |
| 96 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.92183902 |
| 97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91843085 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91243468 |
| 99 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90769016 |
| 100 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.89708268 |
| 101 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88065285 |
| 102 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87087204 |
| 103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85835868 |
| 104 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.85281638 |
| 105 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.83264869 |
| 106 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.82594529 |
| 107 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.80884755 |
| 108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.80786119 |
| 109 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79346683 |
| 110 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.79069071 |
| 111 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78515597 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78345256 |
| 113 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78286011 |
| 114 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.78002176 |
| 115 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.77413383 |
| 116 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.77324069 |
| 117 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.77004776 |
| 118 | UTX_26944678_Chip-Seq_JUKART_Human | 0.76984088 |
| 119 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.76318486 |
| 120 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.75737206 |
| 121 | * CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.74841066 |
| 122 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.71861753 |
| 123 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71217807 |
| 124 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.70953050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001835_abnormal_antigen_presentation | 3.83929387 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.36506614 |
| 3 | MP0003436_decreased_susceptibility_to | 3.30653557 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.10404166 |
| 5 | * MP0002419_abnormal_innate_immunity | 3.09774843 |
| 6 | MP0009785_altered_susceptibility_to | 3.01504000 |
| 7 | MP0003303_peritoneal_inflammation | 2.67040259 |
| 8 | * MP0005000_abnormal_immune_tolerance | 2.66026371 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.57687190 |
| 10 | MP0008438_abnormal_cutaneous_collagen | 2.47097884 |
| 11 | * MP0005025_abnormal_response_to | 2.45415747 |
| 12 | * MP0006082_CNS_inflammation | 2.37731345 |
| 13 | MP0008260_abnormal_autophagy | 2.34332013 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.32931871 |
| 15 | * MP0003724_increased_susceptibility_to | 2.32820781 |
| 16 | MP0001790_abnormal_immune_system | 2.28794544 |
| 17 | MP0005387_immune_system_phenotype | 2.28794544 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.23781771 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.21809540 |
| 20 | MP0005451_abnormal_body_composition | 2.11080920 |
| 21 | MP0000343_altered_response_to | 2.10376736 |
| 22 | MP0005671_abnormal_response_to | 2.09258618 |
| 23 | MP0000569_abnormal_digit_pigmentation | 2.07942085 |
| 24 | MP0000685_abnormal_immune_system | 2.07424433 |
| 25 | MP0001800_abnormal_humoral_immune | 2.07346332 |
| 26 | * MP0002723_abnormal_immune_serum | 2.03727202 |
| 27 | * MP0001533_abnormal_skeleton_physiology | 1.99780369 |
| 28 | MP0004510_myositis | 1.97654905 |
| 29 | * MP0001819_abnormal_immune_cell | 1.90780968 |
| 30 | * MP0002420_abnormal_adaptive_immunity | 1.89061549 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.88569796 |
| 32 | MP0003448_altered_tumor_morphology | 1.78418723 |
| 33 | MP0009278_abnormal_bone_marrow | 1.70849971 |
| 34 | MP0002006_tumorigenesis | 1.65721331 |
| 35 | * MP0001845_abnormal_inflammatory_respons | 1.65279254 |
| 36 | MP0001853_heart_inflammation | 1.64161021 |
| 37 | * MP0002405_respiratory_system_inflammati | 1.62410550 |
| 38 | MP0000858_altered_metastatic_potential | 1.59965658 |
| 39 | MP0002998_abnormal_bone_remodeling | 1.56999241 |
| 40 | MP0003279_aneurysm | 1.56651725 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.53616969 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.52548804 |
| 43 | MP0004947_skin_inflammation | 1.51056247 |
| 44 | MP0006054_spinal_hemorrhage | 1.50094972 |
| 45 | * MP0003075_altered_response_to | 1.44885299 |
| 46 | * MP0009764_decreased_sensitivity_to | 1.43713372 |
| 47 | * MP0008469_abnormal_protein_level | 1.42205522 |
| 48 | MP0005174_abnormal_tail_pigmentation | 1.42014826 |
| 49 | MP0001958_emphysema | 1.40199911 |
| 50 | MP0009840_abnormal_foam_cell | 1.35516690 |
| 51 | MP0010307_abnormal_tumor_latency | 1.33259209 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.32264216 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.31538509 |
| 54 | MP0001545_abnormal_hematopoietic_system | 1.31538509 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.30750857 |
| 56 | * MP0000716_abnormal_immune_system | 1.30645210 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.29545932 |
| 58 | MP0005310_abnormal_salivary_gland | 1.26162953 |
| 59 | * MP0003828_pulmonary_edema | 1.25788204 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.23907254 |
| 61 | MP0002254_reproductive_system_inflammat | 1.19888667 |
| 62 | * MP0005164_abnormal_response_to | 1.19648816 |
| 63 | * MP0003690_abnormal_glial_cell | 1.18479083 |
| 64 | MP0003705_abnormal_hypodermis_morpholog | 1.17180736 |
| 65 | MP0002933_joint_inflammation | 1.16687780 |
| 66 | MP0000015_abnormal_ear_pigmentation | 1.16685306 |
| 67 | MP0002332_abnormal_exercise_endurance | 1.16535047 |
| 68 | * MP0005166_decreased_susceptibility_to | 1.16206403 |
| 69 | * MP0002398_abnormal_bone_marrow | 1.15533528 |
| 70 | MP0000767_abnormal_smooth_muscle | 1.14501784 |
| 71 | * MP0005390_skeleton_phenotype | 1.13719935 |
| 72 | MP0000604_amyloidosis | 1.13391851 |
| 73 | MP0000371_diluted_coat_color | 1.13312002 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 1.12609843 |
| 75 | * MP0000689_abnormal_spleen_morphology | 1.10986662 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 1.09850218 |
| 77 | MP0005171_absent_coat_pigmentation | 1.09649703 |
| 78 | MP0003045_fibrosis | 1.09647827 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 1.07840811 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 1.07322946 |
| 81 | * MP0002429_abnormal_blood_cell | 1.07081049 |
| 82 | MP0002396_abnormal_hematopoietic_system | 1.05031901 |
| 83 | MP0003866_abnormal_defecation | 1.03111988 |
| 84 | MP0005076_abnormal_cell_differentiation | 1.00764682 |
| 85 | MP0002877_abnormal_melanocyte_morpholog | 0.98113943 |
| 86 | MP0003329_amyloid_beta_deposits | 0.95961652 |
| 87 | * MP0000249_abnormal_blood_vessel | 0.95810081 |
| 88 | * MP0000465_gastrointestinal_hemorrhage | 0.95571634 |
| 89 | * MP0002722_abnormal_immune_system | 0.94902288 |
| 90 | MP0001851_eye_inflammation | 0.93485340 |
| 91 | MP0005275_abnormal_skin_tensile | 0.92211299 |
| 92 | MP0004381_abnormal_hair_follicle | 0.91542876 |
| 93 | MP0003221_abnormal_cardiomyocyte_apopto | 0.90794836 |
| 94 | MP0000490_abnormal_crypts_of | 0.90113700 |
| 95 | MP0001873_stomach_inflammation | 0.88619273 |
| 96 | * MP0004883_abnormal_blood_vessel | 0.88613092 |
| 97 | MP0003091_abnormal_cell_migration | 0.85260451 |
| 98 | MP0009763_increased_sensitivity_to | 0.83721440 |
| 99 | MP0000703_abnormal_thymus_morphology | 0.83635252 |
| 100 | MP0005023_abnormal_wound_healing | 0.83583905 |
| 101 | * MP0003795_abnormal_bone_structure | 0.81836576 |
| 102 | MP0000920_abnormal_myelination | 0.80295772 |
| 103 | MP0008004_abnormal_stomach_pH | 0.79885382 |
| 104 | MP0001879_abnormal_lymphatic_vessel | 0.78840237 |
| 105 | MP0001542_abnormal_bone_strength | 0.76713760 |
| 106 | MP0001663_abnormal_digestive_system | 0.74265925 |
| 107 | MP0000372_irregular_coat_pigmentation | 0.74076602 |
| 108 | MP0001915_intracranial_hemorrhage | 0.74041679 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.73539973 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.72434144 |
| 111 | MP0002295_abnormal_pulmonary_circulatio | 0.71239939 |
| 112 | MP0000733_abnormal_muscle_development | 0.70568044 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.69827927 |
| 114 | MP0008874_decreased_physiological_sensi | 0.67488272 |
| 115 | MP0005165_increased_susceptibility_to | 0.55780779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.75184236 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.33059826 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.93554378 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 5.19296860 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.14029649 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 4.94609093 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.60418903 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 4.55042315 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.12998511 |
| 10 | Gastrointestinal infarctions (HP:0005244) | 3.77443491 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.66761673 |
| 12 | Glomerulonephritis (HP:0000099) | 3.64528446 |
| 13 | Dysostosis multiplex (HP:0000943) | 3.64095570 |
| 14 | Gingivitis (HP:0000230) | 3.56276775 |
| 15 | Amyloidosis (HP:0011034) | 3.49366479 |
| 16 | Myocardial infarction (HP:0001658) | 3.48941756 |
| 17 | Recurrent skin infections (HP:0001581) | 3.46894407 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.35993994 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.35993994 |
| 20 | Abnormality of glycolipid metabolism (HP:0010969) | 3.35993994 |
| 21 | Axonal loss (HP:0003447) | 3.34957838 |
| 22 | Disinhibition (HP:0000734) | 3.32896886 |
| 23 | Peritonitis (HP:0002586) | 3.30674782 |
| 24 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.23547898 |
| 25 | Osteolytic defects of the hand bones (HP:0009699) | 3.23547898 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.21798886 |
| 27 | Mucopolysacchariduria (HP:0008155) | 3.21798886 |
| 28 | Prostate neoplasm (HP:0100787) | 3.21397879 |
| 29 | Obstructive lung disease (HP:0006536) | 3.18179465 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.18179465 |
| 31 | T lymphocytopenia (HP:0005403) | 3.16461098 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.15885171 |
| 33 | Periodontitis (HP:0000704) | 3.09653878 |
| 34 | Hematochezia (HP:0002573) | 3.08116831 |
| 35 | * Keratoconjunctivitis sicca (HP:0001097) | 3.06220300 |
| 36 | * Myositis (HP:0100614) | 3.06209381 |
| 37 | Recurrent fungal infections (HP:0002841) | 3.06057288 |
| 38 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.04331511 |
| 39 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.04331511 |
| 40 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.04331511 |
| 41 | Cellulitis (HP:0100658) | 3.01294667 |
| 42 | Abnormality of T cell number (HP:0011839) | 3.01216244 |
| 43 | Spontaneous hematomas (HP:0007420) | 2.92602616 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 2.87752651 |
| 45 | Chest pain (HP:0100749) | 2.87242032 |
| 46 | Osteomyelitis (HP:0002754) | 2.81819822 |
| 47 | Thick nail (HP:0001805) | 2.81253107 |
| 48 | * Hemoptysis (HP:0002105) | 2.79277313 |
| 49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.78896017 |
| 50 | * Keratoconjunctivitis (HP:0001096) | 2.75864980 |
| 51 | Episodic fever (HP:0001954) | 2.75135962 |
| 52 | Interstitial pulmonary disease (HP:0006530) | 2.73843374 |
| 53 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.70020584 |
| 54 | Nephritis (HP:0000123) | 2.69910194 |
| 55 | * Orchitis (HP:0100796) | 2.60212347 |
| 56 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.59684830 |
| 57 | * Encephalitis (HP:0002383) | 2.57399860 |
| 58 | Recurrent viral infections (HP:0004429) | 2.57039168 |
| 59 | Vascular tortuosity (HP:0004948) | 2.56892537 |
| 60 | Pustule (HP:0200039) | 2.52321123 |
| 61 | Increased IgE level (HP:0003212) | 2.51168344 |
| 62 | Cervical subluxation (HP:0003308) | 2.46995395 |
| 63 | Basal ganglia calcification (HP:0002135) | 2.44929191 |
| 64 | Agnosia (HP:0010524) | 2.44304517 |
| 65 | Facial diplegia (HP:0001349) | 2.41015571 |
| 66 | Recurrent pneumonia (HP:0006532) | 2.40106946 |
| 67 | Abnormality of the peritoneum (HP:0002585) | 2.35301592 |
| 68 | Abnormality of complement system (HP:0005339) | 2.34281363 |
| 69 | Arterial tortuosity (HP:0005116) | 2.34051909 |
| 70 | Cerebral aneurysm (HP:0004944) | 2.32196472 |
| 71 | Stomatitis (HP:0010280) | 2.30389568 |
| 72 | Petechiae (HP:0000967) | 2.30009702 |
| 73 | * Pulmonary embolism (HP:0002204) | 2.27465990 |
| 74 | Hepatosplenomegaly (HP:0001433) | 2.26821135 |
| 75 | Spondylolisthesis (HP:0003302) | 2.24995528 |
| 76 | * Arterial thrombosis (HP:0004420) | 2.23847145 |
| 77 | Aortic aneurysm (HP:0004942) | 2.22350804 |
| 78 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.20684124 |
| 79 | Subacute progressive viral hepatitis (HP:0006572) | 2.20325653 |
| 80 | Complement deficiency (HP:0004431) | 2.18972811 |
| 81 | * Vasculitis (HP:0002633) | 2.17730465 |
| 82 | Recurrent cutaneous fungal infections (HP:0011370) | 2.17490636 |
| 83 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.17490636 |
| 84 | Colitis (HP:0002583) | 2.17192683 |
| 85 | Urticaria (HP:0001025) | 2.15324044 |
| 86 | Albinism (HP:0001022) | 2.13240315 |
| 87 | Prolonged bleeding time (HP:0003010) | 2.11301240 |
| 88 | Loss of speech (HP:0002371) | 2.09599924 |
| 89 | Recurrent lower respiratory tract infections (HP:0002783) | 2.09491219 |
| 90 | Absent frontal sinuses (HP:0002688) | 2.09264644 |
| 91 | Joint hemorrhage (HP:0005261) | 2.08751018 |
| 92 | * Gangrene (HP:0100758) | 2.08214025 |
| 93 | Pathologic fracture (HP:0002756) | 2.07690385 |
| 94 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.06003571 |
| 95 | Abnormality of T cells (HP:0002843) | 2.05943247 |
| 96 | Abnormality of the lumbar spine (HP:0100712) | 2.05636820 |
| 97 | * Meningitis (HP:0001287) | 2.04415080 |
| 98 | Sepsis (HP:0100806) | 2.01997949 |
| 99 | Abnormality of the prostate (HP:0008775) | 2.01167857 |
| 100 | Bone pain (HP:0002653) | 2.00900834 |
| 101 | Vertebral compression fractures (HP:0002953) | 2.00605146 |
| 102 | J-shaped sella turcica (HP:0002680) | 2.00120772 |
| 103 | Granulocytopenia (HP:0001913) | 1.99306628 |
| 104 | Increased IgM level (HP:0003496) | 1.98530217 |
| 105 | Gingival bleeding (HP:0000225) | 1.98145106 |
| 106 | Inflammation of the large intestine (HP:0002037) | 1.98106734 |
| 107 | Chronic otitis media (HP:0000389) | 1.98067555 |
| 108 | * Anorexia (HP:0002039) | 1.97552594 |
| 109 | Gastrointestinal inflammation (HP:0004386) | 1.95828249 |
| 110 | Slow saccadic eye movements (HP:0000514) | 1.95603722 |
| 111 | Aortic dissection (HP:0002647) | 1.94964910 |
| 112 | Premature loss of primary teeth (HP:0006323) | 1.94485629 |
| 113 | Viral hepatitis (HP:0006562) | 1.94066619 |
| 114 | Epistaxis (HP:0000421) | 1.92579929 |
| 115 | Polycythemia (HP:0001901) | 1.92571655 |
| 116 | Eosinophilia (HP:0001880) | 1.92554266 |
| 117 | * Vertigo (HP:0002321) | 1.92310613 |
| 118 | Impaired platelet aggregation (HP:0003540) | 1.92039503 |
| 119 | Abnormal platelet function (HP:0011869) | 1.92039503 |
| 120 | Thrombocytosis (HP:0001894) | 1.90883299 |
| 121 | * Abnormality of the endocardium (HP:0004306) | 1.90862830 |
| 122 | * Abnormality of the pleura (HP:0002103) | 1.89278321 |
| 123 | Increased CSF protein (HP:0002922) | 1.88649024 |
| 124 | * Retrobulbar optic neuritis (HP:0100654) | 1.87378025 |
| 125 | * Optic neuritis (HP:0100653) | 1.87378025 |
| 126 | * Glomerulopathy (HP:0100820) | 1.86722472 |
| 127 | Increased serum ferritin (HP:0003281) | 1.86161281 |
| 128 | Hypergammaglobulinemia (HP:0010702) | 1.85949004 |
| 129 | Amaurosis fugax (HP:0100576) | 1.85887503 |
| 130 | Leukocytosis (HP:0001974) | 1.84013780 |
| 131 | * Pulmonary infiltrates (HP:0002113) | 1.83793794 |
| 132 | Tetraparesis (HP:0002273) | 1.82502508 |
| 133 | Upper motor neuron abnormality (HP:0002127) | 1.82156552 |
| 134 | * Polyneuropathy (HP:0001271) | 1.79949541 |
| 135 | Esophageal varix (HP:0002040) | 1.79787865 |
| 136 | Neurofibrillary tangles (HP:0002185) | 1.78763409 |
| 137 | Cheilitis (HP:0100825) | 1.78465504 |
| 138 | Skin ulcer (HP:0200042) | 1.77414605 |
| 139 | Asymmetric septal hypertrophy (HP:0001670) | 1.76505703 |
| 140 | Purpura (HP:0000979) | 1.75002169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 3.61282941 |
| 2 | BLK | 3.54311824 |
| 3 | MAP3K14 | 3.31395363 |
| 4 | RIPK4 | 3.25031757 |
| 5 | IRAK4 | 3.02371448 |
| 6 | KIT | 2.69901391 |
| 7 | TBK1 | 2.68767761 |
| 8 | ERN1 | 2.40303415 |
| 9 | TYK2 | 2.32329487 |
| 10 | PRPF4B | 2.25324804 |
| 11 | IRAK3 | 2.22353586 |
| 12 | MAP4K1 | 2.17322714 |
| 13 | NEK9 | 2.02589483 |
| 14 | TEC | 1.90172101 |
| 15 | IKBKB | 1.89380644 |
| 16 | CSF1R | 1.86461891 |
| 17 | IKBKE | 1.85917486 |
| 18 | JAK3 | 1.85244954 |
| 19 | TIE1 | 1.83499973 |
| 20 | JAK1 | 1.75798963 |
| 21 | TXK | 1.75090643 |
| 22 | TTN | 1.68981373 |
| 23 | ZAP70 | 1.66763437 |
| 24 | IRAK1 | 1.66397128 |
| 25 | BTK | 1.66360374 |
| 26 | IRAK2 | 1.55601847 |
| 27 | TRPM7 | 1.51270816 |
| 28 | CAMK1D | 1.47926349 |
| 29 | HCK | 1.45157304 |
| 30 | KSR2 | 1.42156948 |
| 31 | MAP3K1 | 1.40029724 |
| 32 | CSK | 1.39553433 |
| 33 | GRK6 | 1.37961515 |
| 34 | PIM2 | 1.35718495 |
| 35 | EPHB1 | 1.34133677 |
| 36 | GRK7 | 1.29947261 |
| 37 | MAP3K2 | 1.29659921 |
| 38 | SYK | 1.26169884 |
| 39 | TAOK1 | 1.26053816 |
| 40 | TAOK3 | 1.22630571 |
| 41 | STK10 | 1.22556488 |
| 42 | LYN | 1.19845643 |
| 43 | MAP3K11 | 1.16550847 |
| 44 | FGFR3 | 1.13775703 |
| 45 | MAP3K6 | 1.13688343 |
| 46 | FRK | 1.13591723 |
| 47 | PAK4 | 1.13043610 |
| 48 | TNK2 | 1.08994784 |
| 49 | CHUK | 1.08951778 |
| 50 | RIPK1 | 1.05514677 |
| 51 | PBK | 1.04779706 |
| 52 | MARK3 | 1.02255028 |
| 53 | TRIB3 | 0.99237106 |
| 54 | ZAK | 0.99158071 |
| 55 | LCK | 0.98124057 |
| 56 | PIK3CG | 0.98040239 |
| 57 | MATK | 0.96240247 |
| 58 | CDK6 | 0.95901720 |
| 59 | MAP2K3 | 0.95347542 |
| 60 | YES1 | 0.93125133 |
| 61 | PKN2 | 0.92157531 |
| 62 | MAP3K13 | 0.91933617 |
| 63 | LRRK2 | 0.91699277 |
| 64 | BMX | 0.90585037 |
| 65 | ITK | 0.89880719 |
| 66 | CAMKK2 | 0.89731878 |
| 67 | NME2 | 0.89596394 |
| 68 | STK3 | 0.89556011 |
| 69 | TAOK2 | 0.88226464 |
| 70 | PTK6 | 0.87841000 |
| 71 | ERBB3 | 0.86781343 |
| 72 | NUAK1 | 0.84119327 |
| 73 | EPHA3 | 0.84019310 |
| 74 | FES | 0.83662707 |
| 75 | MST1R | 0.82797855 |
| 76 | JAK2 | 0.82708873 |
| 77 | MARK2 | 0.81589605 |
| 78 | PDK1 | 0.80765001 |
| 79 | EIF2AK2 | 0.78759622 |
| 80 | ABL1 | 0.78668974 |
| 81 | PDPK1 | 0.77512418 |
| 82 | MAP3K5 | 0.76924714 |
| 83 | CAMK1G | 0.76761509 |
| 84 | FGR | 0.76634595 |
| 85 | CDC42BPA | 0.75911316 |
| 86 | PIM1 | 0.74973180 |
| 87 | MAP3K3 | 0.73914777 |
| 88 | PDK2 | 0.72538738 |
| 89 | MAP3K12 | 0.72254015 |
| 90 | KSR1 | 0.72196489 |
| 91 | CLK1 | 0.69673965 |
| 92 | EGFR | 0.68458210 |
| 93 | ACVR1B | 0.67859387 |
| 94 | RPS6KA4 | 0.64321642 |
| 95 | STK4 | 0.63438303 |
| 96 | SGK2 | 0.63193918 |
| 97 | RAF1 | 0.62782365 |
| 98 | PRKCD | 0.62568282 |
| 99 | ADRBK2 | 0.60927419 |
| 100 | BMPR2 | 0.60866969 |
| 101 | MAPK7 | 0.60183778 |
| 102 | SCYL2 | 0.59228082 |
| 103 | MAP2K4 | 0.59152447 |
| 104 | FGFR4 | 0.58983400 |
| 105 | SIK3 | 0.58528918 |
| 106 | MOS | 0.56510713 |
| 107 | PDGFRB | 0.55210991 |
| 108 | IGF1R | 0.54071271 |
| 109 | ABL2 | 0.53509054 |
| 110 | NLK | 0.53179723 |
| 111 | WNK1 | 0.52710265 |
| 112 | PTK2B | 0.51637387 |
| 113 | MST4 | 0.50186556 |
| 114 | TGFBR1 | 0.50085421 |
| 115 | RET | 0.47244830 |
| 116 | STK24 | 0.46765060 |
| 117 | MYLK | 0.46130913 |
| 118 | SIK1 | 0.45182969 |
| 119 | MAPKAPK2 | 0.42249574 |
| 120 | FLT3 | 0.41960477 |
| 121 | RPS6KA6 | 0.40053323 |
| 122 | PRKD2 | 0.39697169 |
| 123 | DAPK2 | 0.37682677 |
| 124 | SIK2 | 0.37316131 |
| 125 | HIPK2 | 0.35837619 |
| 126 | STK11 | 0.35457190 |
| 127 | DYRK1B | 0.35084188 |
| 128 | FYN | 0.35016442 |
| 129 | SGK3 | 0.34312483 |
| 130 | MAP2K6 | 0.33780593 |
| 131 | MAPK12 | 0.33018460 |
| 132 | INSR | 0.31229477 |
| 133 | PRKCQ | 0.30608452 |
| 134 | RPS6KC1 | 0.30516403 |
| 135 | RPS6KL1 | 0.30516403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.68336289 |
| 2 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.11916512 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.83166601 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 2.65490840 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.56953724 |
| 6 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.53390476 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.52822363 |
| 8 | * Pertussis_Homo sapiens_hsa05133 | 2.29479107 |
| 9 | * Legionellosis_Homo sapiens_hsa05134 | 2.28845484 |
| 10 | * Tuberculosis_Homo sapiens_hsa05152 | 2.27816905 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.13222168 |
| 12 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.12076945 |
| 13 | * Malaria_Homo sapiens_hsa05144 | 2.11445393 |
| 14 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.06923860 |
| 15 | * Phagosome_Homo sapiens_hsa04145 | 1.99977610 |
| 16 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.83175774 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.82046252 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.77098860 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.74216511 |
| 20 | * Measles_Homo sapiens_hsa05162 | 1.73812326 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.69732003 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.68830732 |
| 23 | * Salmonella infection_Homo sapiens_hsa05132 | 1.66007744 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.51746167 |
| 25 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.49062983 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.48828697 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.48053904 |
| 28 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45148106 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44560480 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.43227522 |
| 31 | * Influenza A_Homo sapiens_hsa05164 | 1.42925161 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.39901269 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.34317091 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.32532702 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.30974733 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.26088174 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24674071 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.23958878 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.21794335 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19590422 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.18913547 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17586970 |
| 43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16121473 |
| 44 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15112390 |
| 45 | * Amoebiasis_Homo sapiens_hsa05146 | 1.12805436 |
| 46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.12087002 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.10904114 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.10528049 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.08071681 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04150510 |
| 51 | * Hepatitis B_Homo sapiens_hsa05161 | 1.00085052 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97066144 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.96403034 |
| 54 | * Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95814237 |
| 55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.95326094 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91841661 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89527788 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.89187596 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88905230 |
| 60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86283595 |
| 61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81913936 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81694204 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.81408179 |
| 64 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72462622 |
| 65 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.69676182 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68320658 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67933846 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.66132504 |
| 69 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65566487 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64777048 |
| 71 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.64734069 |
| 72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64634043 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64185847 |
| 74 | Focal adhesion_Homo sapiens_hsa04510 | 0.64169615 |
| 75 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.63932754 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62287094 |
| 77 | Endometrial cancer_Homo sapiens_hsa05213 | 0.61436884 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60958596 |
| 79 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60283533 |
| 80 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.59906418 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59638887 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57498245 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.56752927 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55493735 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55058838 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52904648 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52507161 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52244687 |
| 89 | Adherens junction_Homo sapiens_hsa04520 | 0.52157450 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51255911 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49871885 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49773984 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.46415572 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45795153 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45571104 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.45541003 |
| 97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.44474672 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43741191 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43312912 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.42690746 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42674791 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41963715 |
| 103 | Glioma_Homo sapiens_hsa05214 | 0.41379740 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41144037 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41141460 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40979586 |
| 107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40845502 |
| 108 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39698813 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38608133 |
| 110 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38590879 |
| 111 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38534859 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37258285 |
| 113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34878460 |
| 114 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34869902 |
| 115 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.34478580 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31813915 |
| 117 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29593111 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | 0.29524791 |
| 119 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28086295 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.27737709 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.26949990 |
| 122 | Melanoma_Homo sapiens_hsa05218 | 0.26000701 |
| 123 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.25716165 |
| 124 | HTLV-I infection_Homo sapiens_hsa05166 | 0.23974399 |
| 125 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.22009555 |

